Thermo Fisher Scientific, Inc. (TMO) Financials
Key financial figures for Thermo Fisher Scientific, Inc. (Q3 2026).
Thermo Fisher Q3 2026 revenue grew 9% to $12.14B (organic +6%) and adjusted EPS grew 15% to $6.68. Revenue was $12,137M versus $11,122M a year earlier (+9%). The release attributes 3 points to acquisitions/divestitures and 0 to currency, leaving organic revenue growth (non-GAAP) of 6%. GAAP diluted EPS was $4.64 versus $4.27 (+9%). GAAP operating income was $2,263M versus $1,941M (+17%), a margin of 18.6% versus 17.4%. Adjusted EPS (non-GAAP) was $6.68 versus $5.79 (+15%). Adjusted operating income was $2,968M versus $2,587M, a margin of 24.5% versus 23.3%. Figures are for Q3 2026, as Thermo Fisher Scientific Inc. reported them.
- Revenue
- $12.1B
- Net Income
- $1.7B
- EPS
- $4.65
- Total Assets
- $114.2B
- Operating Cash Flow
- $2.5B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $12.1B | $1.7B | $4.64 | 18.65% | $2.1B |
| Q2 FY2026 | $12.0B | $1.7B | $4.68 | 17.4% | $1.7B |
| Q1 FY2026 | $11.0B | $1.7B | $4.43 | 16.93% | $816M |
| Q4 FY2025 | $12.2B | $2.0B | $5.21 | 18.85% | $3.0B |
| Q3 FY2025 | $11.1B | $1.6B | $4.27 | 18.66% | $1.8B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $44.6B | $6.7B | $17.74 | 18.2% | $6.3B |
| FY2024 | $42.9B | $6.3B | $16.53 | 17.87% | $7.3B |
| FY2023 | $42.9B | $6.0B | $15.45 | 17.37% | $6.9B |
Frequently asked questions
What was Thermo Fisher Scientific Inc.'s revenue last quarter?
Thermo Fisher Scientific Inc. reported revenue of $12.14 billion for Q3 FY2026, up 9.1% from the same period a year earlier.
Is Thermo Fisher Scientific Inc. profitable?
Yes. Thermo Fisher Scientific Inc. reported net income of $1.72 billion for Q3 FY2026, a net margin of 14.18% on revenue.
How has Thermo Fisher Scientific Inc.'s margin trended?
Operating margin was 18.65% in Q3 FY2026. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Thermo Fisher Scientific Inc. generate?
Thermo Fisher Scientific Inc. generated free cash flow of $2.11 billion in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Thermo Fisher Scientific, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.